Search Results

The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson's disease.

• Authors : Li, Hangzhen; Zeng, Fancai; Huang, Cancan

Subjects: AMINO acid metabolism; LIPID metabolism; PARKINSON'S disease

• Source: CNS Neuroscience & Therapeutics; Feb2024, Vol. 30 Issue 2, p1-14, 14p

Record details

Heart valve disease associated with treatment with ergot-derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson’s disease.

• Authors : Rasmussen, V. G.; Poulsen, S. H.; Dupont, E.

Subjects: HEART valve diseases; DOPAMINE; PARKINSON'S disease

• Source: Journal of Internal Medicine; Jan2008, Vol. 263 Issue 1, p90-98, 9p, 4 Charts

Record details

Dopamine agonists in the treatment of non-motor symptoms of Parkinson’s disease: depression.

• Authors : Lemke, M. R.

Subjects: DOPAMINE agonists; PARKINSON'S disease; MENTAL depression

• Source: European Journal of Neurology; Apr2008 Supplement 2, Vol. 15, p9-14, 6p, 1 Chart, 3 Graphs

Record details

Constant dopaminergic stimulation by transdermal delivery of dopaminergic drugs: a new treatment paradigm in Parkinson's disease.

• Authors : Steiger, M.

Subjects: DOPAMINE receptors; PARKINSON'S disease; CLINICAL trials

• Source: European Journal of Neurology; Jan2008, Vol. 15 Issue 1, p2-11, 10p, 2 Charts, 1 Graph

Record details

Study assesses efficacy of high-dose cabergoline in Parkinson's disease.

Subjects: *CLINICAL trials; *PARKINSON'S disease; *DOPAMINE agonistsUNITED States

• Source: Brown University Geriatric Psychopharmacology Update. Feb2006, Vol. 10 Issue 2, p1-6. 3p.

Record details

Oestrogen Regulates the Expression and Function of Dopamine Transporters in Astrocytes of the Nigrostriatal System.

• Authors : Karakaya, S.; Kipp, M.; Beyer, C.

Subjects: ESTROGEN; DOPAMINE; ASTROCYTES

• Source: Journal of Neuroendocrinology; Sep2007, Vol. 19 Issue 9, p682-690, 9p, 1 Black and White Photograph, 3 Graphs

Record details

A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.

• Authors : Zafar, Khan Shoeb; Inayat-Hussain, Salmaan H.; Ross, David

Subjects: APOPTOSIS; DOPAMINE; PARKINSON'S disease

• Source: Journal of Neurochemistry; Aug2007, Vol. 102 Issue 3, p913-921, 9p, 6 Graphs

Record details

Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.

• Authors : Salvatore, Michael F.; Jin-Lu Zhang; Large, Delia M.

Subjects: PARKINSON'S disease; AGING; DOPAMINE

• Source: Journal of Neurochemistry; 7/1/2004, Vol. 90 Issue 1, p245-254, 10p

Record details

Molecular imaging in hereditary forms of parkinsonism.

• Authors : Shih, M. C.; Felicio, A. C.; de Oliveira Godeiro-Junior, C.

Subjects: PARKINSON'S disease & genetics; PATHOLOGICAL physiology; DOPAMINE receptors

• Source: European Journal of Neurology; Apr2007, Vol. 14 Issue 4, p359-368, 10p, 2 Charts

Record details

Dopaminergic neurons intrinsic to the striatum.

• Authors : Huot, Philippe; Parent, Andr

Subjects: DOPAMINERGIC neurons; BASAL ganglia; DOPAMINE

• Source: Journal of Neurochemistry; Jun2007, Vol. 101 Issue 6, p1441-1447, 7p, 2 Diagrams

Record details